Massachusetts Financial Services’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$30.7M Sell
33,372
-5,095
-13% -$5.17M 0.01% 564
2025
Q4
$41.3M Buy
38,467
+8,223
+27% +$7.86M 0.01% 509
2025
Q3
$23.1M Sell
30,244
-188,614
-86% -$140M 0.01% 611
2025
Q2
$171M Sell
218,858
-617,976
-74% -$480M 0.05% 307
2025
Q1
$691M Sell
836,834
-208,384
-20% -$173M 0.23% 124
2024
Q4
$807M Sell
1,045,218
-885,650
-46% -$733M 0.25% 109
2024
Q3
$1.71B Sell
1,930,868
-633,763
-25% -$570M 0.51% 53
2024
Q2
$2.32B Sell
2,564,631
-548,449
-18% -$439M 0.71% 26
2024
Q1
$2.42B Sell
3,113,080
-100,277
-3% -$71.4M 0.72% 28
2023
Q4
$1.87B Sell
3,213,357
-97,502
-3% -$56.9M 0.6% 42
2023
Q3
$1.78B Buy
3,310,859
+645,473
+24% +$333M 0.62% 37
2023
Q2
$1.25B Buy
2,665,386
+1,672,502
+168% +$701M 0.41% 72
2023
Q1
$341M Sell
992,884
-75,724
-7% -$25.5M 0.12% 179
2022
Q4
$391M Sell
1,068,608
-205,748
-16% -$72.9M 0.14% 163
2022
Q3
$412M Sell
1,274,356
-109,138
-8% -$34.6M 0.15% 154
2022
Q2
$449M Sell
1,383,494
-111,505
-7% -$33.5M 0.15% 152
2022
Q1
$428M Sell
1,494,999
-107,545
-7% -$27.7M 0.13% 170
2021
Q4
$443M Sell
1,602,544
-289,920
-15% -$73.5M 0.12% 174
2021
Q3
$437M Sell
1,892,464
-292,327
-13% -$72.1M 0.13% 167
2021
Q2
$501M Sell
2,184,791
-384,346
-15% -$77.2M 0.15% 159
2021
Q1
$480M Sell
2,569,137
-790,114
-24% -$155M 0.15% 151
2020
Q4
$567M Sell
3,359,251
-1,138,872
-25% -$170M 0.18% 134
2020
Q3
$666M Sell
4,498,123
-354,538
-7% -$54.9M 0.24% 110
2020
Q2
$797M Sell
4,852,661
-242,852
-5% -$37.3M 0.31% 88
2020
Q1
$707M Sell
5,095,513
-954,817
-16% -$131M 0.34% 84
2019
Q4
$795M Sell
6,050,330
-392,473
-6% -$45.5M 0.3% 90
2019
Q3
$720M Buy
6,442,803
+628,267
+11% +$69.9M 0.29% 93
2019
Q2
$644M Buy
5,814,536
+660,406
+13% +$77.8M 0.26% 100
2019
Q1
$669M Buy
5,154,130
+544,732
+12% +$66.2M 0.28% 98
2018
Q4
$533M Sell
4,609,398
-101,408
-2% -$11.3M 0.26% 101
2018
Q3
$506M Sell
4,710,806
-2,553,321
-35% -$255M 0.21% 119
2018
Q2
$620M Sell
7,264,127
-712,576
-9% -$58.5M 0.27% 103
2018
Q1
$617M Sell
7,976,703
-424,122
-5% -$34.1M 0.26% 101
2017
Q4
$710M Sell
8,400,825
-1,720,464
-17% -$146M 0.3% 93
2017
Q3
$866M Sell
10,121,289
-53,026
-0.5% -$4.35M 0.38% 73
2017
Q2
$837M Sell
10,174,315
-594,866
-6% -$48.5M 0.37% 73
2017
Q1
$906M Sell
10,769,181
-1,175,961
-10% -$94.2M 0.42% 65
2016
Q4
$879M Buy
11,945,142
+169,024
+1% +$12.6M 0.43% 68
2016
Q3
$945M Sell
11,776,118
-136,889
-1% -$11M 0.46% 64
2016
Q2
$938M Buy
11,913,007
+715,620
+6% +$53.9M 0.47% 62
2016
Q1
$806M Buy
11,197,387
+1,845,424
+20% +$140M 0.42% 71
2015
Q4
$788M Buy
9,351,963
+747,915
+9% +$62.1M 0.42% 70
2015
Q3
$720M Buy
8,604,048
+1,494,998
+21% +$126M 0.4% 75
2015
Q2
$594M Buy
7,109,050
+3,135,411
+79% +$239M 0.3% 89
2015
Q1
$289M Buy
3,973,639
+1,288,654
+48% +$91.7M 0.15% 150
2014
Q4
$185M Buy
2,684,985
+1,990,917
+287% +$134M 0.09% 190
2014
Q3
$45M Sell
694,068
-53,361
-7% -$3.38M 0.02% 364
2014
Q2
$46.5M Buy
747,429
+4,461
+0.6% +$266K 0.02% 361
2014
Q1
$43.7M Sell
742,968
-58,550
-7% -$3.27M 0.02% 364
2013
Q4
$40.9M Sell
801,518
-10,890
-1% -$545K 0.02% 373
2013
Q3
$40.9M Sell
812,408
-123,760
-13% -$6.48M 0.03% 355
2013
Q2
$46M Buy
+936,168
New +$50.9M 0.03% 333

Other funds holding LLY

Massachusetts Financial Services's LLY Position: Q1 2026 in Review

Massachusetts Financial Services reduced its Eli Lilly (LLY) stake by 13% in Q1 2026, selling an estimated $5.17M and leaving 33,372 shares worth $30.7M. The position accounts for 0.01% of the portfolio, ranked #564.

Massachusetts Financial Services first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.42B in Q1 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Massachusetts Financial Services held 33,372 shares of Eli Lilly worth $30.7M as of Q1 2026.
  • Massachusetts Financial Services sold 5,095 Eli Lilly shares in Q1 2026, an estimated $5.17M.
  • Eli Lilly made up 0.01% of Massachusetts Financial Services's portfolio in Q1 2026, its #564 holding.
  • Massachusetts Financial Services first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Massachusetts Financial Services's Eli Lilly position peaked at $2.42B in Q1 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Massachusetts Financial Services's 13F filing for Q1 2026, filed 14 May 2026.